Biomerics announces move to new corporate headquarters

The new facility will include a cleanroom and is to be FDA and ISO-13485 registered for medical device manufacturing

Rendered image of Biomerics Corporate Headquarters

Biomerics, a leading US-based medical device manufacturer for the cardiovascular market, is relocating to a new corporate headquarters in Salt Lake City, Utah. The 230,000ft2 facility will be located in the International Center west of the Salt Lake City International Airport and will include corporate offices, engineering offices, research and development labs, and cleanroom manufacturing.

Biomerics specialises in the design, development and production of medical devices for diagnostic and interventional procedures for the cardiovascular, structural heart, cardiac rhythm management and vascular access markets. The company, formed in 2009, has grown into a leading supplier for the US$250bn dollar medical device industry. Biomerics has five locations, including facilities in Minnesota, Utah, and Ireland.

The new facility will include a cleanroom and is to be FDA and ISO-13485 registered for medical device manufacturing. The completion of the facility, including commission and validation, is anticipated during the second quarter of 2018. 

"The team has done an excellent job designing a facility that reflects the vision and growth expectations of the company," said Travis Sessions, CEO of Biomerics. "This investment will support the next phase of the company's growth strategy and will expand our device design, development and manufacturing capabilities." The headquarters is engineered to accommodate up to 600 employees and will include a full range of manufacturing technologies including implantable material polymerisation, moulding, extrusion, coating and catheter assembly.

Biomerics expects to invest US$38.5m in the expansion over the next eight years and to add over 380 new jobs. The State of Utah Governor's Office of Economic Development (GOED) announced its support of the project and provided up to US$3m in tax incentives for the investment. 

The location selection process, building design and construction are being managed by Wasatch Commercial Management, Utah's leading commercial real estate development and management company.

"Wasatch specialises in partnering with companies like Biomerics," said John Dahlstrom, Executive Vice President of Wasatch Commercial Management. "We are excited to work on a second facility with Biomerics. Our team and development processes enable clients to envision their future needs and develop space to achieve their goals."